PPAR agonists showed anti-inflammatory and anticatabolic properties in animal models of adjuvant-induced arthritis where PPAR agonists reduced synovial inflammation, while preventing cartilage destruction or loss in bone mineral density [42]. The gene discussed is PPARA; the disease is Arthritis.